返回 Agenda
Session Chair(s)
John Wilkinson
Director of Devices
MHRA, United Kingdom
Speaker(s)
Perspective of a Member State
Matthias Neumann
Federal Ministry of Health (BMG), Germany
Changing Role of Notified Bodies
Gert Bos, PHD, MSC
Qserve Group B.V., Netherlands
Chief Scientific Oficer, Executive Director, Partner
Impact on Industry
Peter Schroeer, RAC
Johnson & Johnson, Germany
Senior Director, Regulatory Policy Innovation
Panel Discussion
Reinhard Berger, DRSC, MSC
Consulting-Advising, Austria
Regulatory Affairs Medical Devices
Panel Discussion
Sabina Hoekstra-van den Bosch, PHARMD, MSC, RPH
Tüv Süd, Netherlands
Global Director Regulatory Strategy